Raymond James & Associates’s UBS AG FI Enhanced Large Cap Growth ETN FBGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-462
Closed -$390K 4112
2024
Q1
$390K Hold
462
﹤0.01% 3218
2023
Q4
$321K Sell
462
-290
-39% -$178K ﹤0.01% 3239
2023
Q3
$413K Hold
752
﹤0.01% 3000
2023
Q2
$450K Buy
752
+290
+63% +$150K ﹤0.01% 3007
2023
Q1
$222K Sell
462
-140
-23% -$60.6K ﹤0.01% 3435
2022
Q4
$228K Sell
602
-39
-6% -$15.5K ﹤0.01% 3375
2022
Q3
$236K Hold
641
﹤0.01% 3344
2022
Q2
$255K Sell
641
-63
-9% -$32.4K ﹤0.01% 3339
2022
Q1
$502K Sell
704
-66
-9% -$45K ﹤0.01% 3070
2021
Q4
$668K Sell
770
-30
-4% -$24.6K ﹤0.01% 2883
2021
Q3
$566K Sell
800
-34
-4% -$25.5K ﹤0.01% 2977
2021
Q2
$578K Buy
834
+172
+26% +$108K ﹤0.01% 2983
2021
Q1
$372K Hold
662
﹤0.01% 3220
2020
Q4
$366K Hold
662
﹤0.01% 3004
2020
Q3
$300K Hold
662
﹤0.01% 2957
2020
Q2
$238K Buy
+662
New +$205K ﹤0.01% 3036

Raymond James & Associates's FBGX Position: Q2 2024 in Review

Raymond James & Associates sold out of UBS AG FI Enhanced Large Cap Growth ETN (FBGX) in Q2 2024, closing a stake of 462 shares — an estimated $390K sold.

Raymond James & Associates first reported a position in FBGX in Q2 2020 and held it in 16 quarters. The position peaked at $668K in Q4 2021. 0 funds tracked by Wall St. Rank hold FBGX as of Q2 2024.

  • Raymond James & Associates reported no remaining UBS AG FI Enhanced Large Cap Growth ETN position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 462 UBS AG FI Enhanced Large Cap Growth ETN shares in Q2 2024, an estimated $390K.
  • Raymond James & Associates first reported a position in UBS AG FI Enhanced Large Cap Growth ETN in Q2 2020 and held it in 16 quarters.
  • Raymond James & Associates's UBS AG FI Enhanced Large Cap Growth ETN position peaked at $668K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held UBS AG FI Enhanced Large Cap Growth ETN as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.